ISSN 2147-9720 | E-ISSN 2148-4279
RELATED ARTICLES
Review
Familial Mediterranean fever: An updated review
(Eur J Rheumatol 2014; 1: 21-33)
DOI: 10.5152/eurjrheum.2014.006
Case Report
A case of neutrophilic dermatosis who develop palpable purpura during the use of montelukast
(Eur J Rheumatol 2014; 1: 170-171)
DOI: 10.5152/eurjrheumatol.2014.140032
Anakinra use during pregnancy: Report of a case with Familial Mediterranean Fever and infertility
(Eur J Rheumatol 2017; 4: 66-67)
DOI: 10.5152/eurjrheum.2017.16075
Muscle weakness as a presenting symptom in ANCA-associated vasculitis
(Eur J Rheumatol 2018; 5: 139-141)
DOI: 10.5152/eurjrheum.2017.17067
Recurrence of proteinuria after cessation of tocilizumab in patients with AA amyloidosis secondary to FMF
(Eur J Rheumatol 2018; 5: 278-280)
DOI: 10.5152/eurjrheum.2018.17183
Recurrence of proteinuria after cessation of tocilizumab in patients with AA amyloidosis secondary to FMF
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.17183
Muscle weakness as a presenting symptom in ANCA-associated vasculitis
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2017.17067
Original Article
Evaluation of arterial stiffness with plasma GGT levels and pulse wave velocity measurement in patients with FMF
(Eur J Rheumatol 2014; 1: 11-13)
DOI: 10.5152/eurjrheum.2014.003
Neutrophil-lymphocyte ratio in children with familial Mediterranean fever: original article
(Eur J Rheumatol 2015; 2: 20-23)
DOI: 10.5152/eurjrheumatol.2015.0093
The role of MEFV mutations in the concurrent disorders observed in patients with familial Mediterranean fever
(Eur J Rheumatol 2016; 3: 118-121)
DOI: 10.5152/eurjrheum.2016.16012
Heart rate variability in familial Mediterranean fever patients
(Eur J Rheumatol 2014; 1: 58-61)
DOI: 10.5152/eurjrheumatol.2014.013
Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis
(Eur J Rheumatol 2014; 1: 101-105)
DOI: 10.5152/eurjrheumatol.2014.034
Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine
(Eur J Rheumatol 2019; 6: 85-88)
DOI: 10.5152/eurjrheum.2019.18190
Immune and inflammatory gene expressions are different in Behçet’s disease compared to those in Familial Mediterranean Fever
(Eur J Rheumatol 2016; 3: 146-152)
DOI: 10.5152/eurjrheum.2016.15099
Musculoskeletal manifestations in pediatric patients infected with human immunodeficiency virus: Developing country perspective
(Eur J Rheumatol 2019; 6: 7-11)
DOI: 10.5152/eurjrheum.2018.18045
Novel presentations of periodic fever syndromes: Discrepancies between genetic and clinical diagnoses
(Eur J Rheumatol 2019; 6: 12-18)
DOI: 10.5152/eurjrheum.2018.18023
Late ventricular potentials in familial Mediterranean fever with and without AA amyloidosis
(Eur J Rheumatol 2017; 4: 184-188)
DOI: 10.5152/eurjrheum.2017.16113
IL1-blocking therapy in colchicine-resistant familial Mediterranean fever
(Eur J Rheumatol 2018; 5: 230-234)
DOI: 10.5152/eurjrheum.2018.18036
Serum lipid changes and insulin resistance in familial Mediterranean fever
(Eur J Rheumatol 2014; 1: 140-143)
DOI: 10.5152/eurjrheumatol.2014.140045
Relationship between endothelial dysfunction and microalbuminuria in familial Mediterranean fever
(Eur J Rheumatol 2016; 3: 61-64)
DOI: 10.5152/eurjrheum.2016.15079
Serological screening for celiac disease in children with systemic lupus erythematosus
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2019.18130
IL1-blocking therapy in colchicine-resistant familial Mediterranean fever
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2018.18036
Invited Review
Updates in ANCA-associated vasculitis
(Eur J Rheumatol 2016; 3: 122-133)
DOI: 10.5152/eurjrheum.2015.0043
Key Words
Authors
All
Author’s Corner
Survey
AVES | Copyright © 2019 Medical Research and Education Association | Latest Update: 08.04.2019